Tarveda Therapeutics
Latest round
- Series D
Last raised
- Jan 2017
Total raised
- $113M
Investors
- 6
About Tarveda Therapeutics
Tarveda Therapeutics, Inc. focuses on developing innovative therapeutics utilizing its proprietary drug delivery platform to enhance cancer treatment outcomes.Founded in 2011 and headquartered in Watertown, US, Tarveda Therapeutics, Inc. is dedicated to developing nanotechnology-based therapeutics for cancer treatment.694 mn.Tarveda Therapeutics specializes in developing innovative drug delivery systems aimed at targeting cancer cells effectively.The company's revenue is primarily generated through the commercialization of its proprietary cancer therapeutics and drug delivery systems. The company is also exploring entry into new global markets, focusing on Europe and Asia by 2025. Their strategy includes launching additional drug candidates that will enhance treatment options for cancer patients, further solidifying their presence in oncology.
Who invested in Tarveda Therapeutics
6 investors across 8 rounds
See all investors in Tarveda Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Jan 31, 2017
Amount
$30M
Investors
Series C
Jan 30, 2017
Amount
$13M
Investors
Series C
Jan 15, 2016
Amount
$26M
Investors
Series B
Jan 7, 2015
Amount
$21M
Investors
Series B
Mar 11, 2014
Amount
$0.5M
Investors
Series B
Dec 23, 2013
Amount
$5M
Investors
Series B
Dec 12, 2012
Amount
$16M
Investors
Series A
Sep 2, 2011
Amount
$2.8M
Investors
Questions about Tarveda Therapeutics
Who invested in Tarveda Therapeutics?
Tarveda Therapeutics has 6 investors on record across 8 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tarveda Therapeutics raised?
Tarveda Therapeutics has raised 8 venture rounds. Sign up free to see how much each round raised and the total.
When did Tarveda Therapeutics last raise money?
Tarveda Therapeutics's most recent round on record is a Series D, in Jan 2017.
What does Tarveda Therapeutics do?
Tarveda Therapeutics is a biotechnology company.
Where is Tarveda Therapeutics headquartered?
Tarveda Therapeutics is headquartered in Watertown, US.
Which VCs invest in companies like Tarveda Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Tarveda Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Tarveda Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.